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This is an open access article distributed under the terms of the Creative Commons Attribution 
License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any 
medium, provided the original work is properly cited. 
ABSTRACT 
The superficial dorsal horn, which is the main target for nociceptive and pruritoceptive primary 
afferents, contains a high density of excitatory interneurons. Our understanding of their roles in 
somatosensory processing has been restricted by the difficulty of distinguishing functional 
populations among these cells. We recently defined three non-overlapping populations among the 
excitatory neurons, based on the expression of neurotensin, neurokinin B (NKB) and gastrin-
releasing peptide (GRP). Here we identify and characterise another population: neurons that express 
the tachykinin peptide substance P. We show with immunocytochemistry that its precursor protein 
(preprotachykinin A, PPTA) can be detected in ~14% of lamina I-II neurons, and these are 
concentrated in the outer part of lamina II. Over 80% of the PPTA-positive cells lack the 
transcription factor Pax2 (which determines an inhibitory phenotype), and these account for ~15% 
of the excitatory neurons in this region. They are different from the neurotensin, NKB or GRP 
neurons, although many of them contain somatostatin, which is widely expressed among superficial 
dorsal horn excitatory interneurons. We show that many of these cells respond to noxious thermal 
and mechanical stimuli, and to intradermal injection of pruritogens. Finally, we demonstrate that 
these cells can also be identified in a knock-in Cre mouse line (Tac1Cre), although our findings 
suggest that there is an additional population of neurons that transiently express PPTA. This 
population of substance P-expressing excitatory neurons is likely to play an important role in 
transmission of signals that are perceived as pain and itch. 
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Introduction 
  The superficial dorsal horn (laminae I-II) is innervated by primary afferents that detect noxious 
and pruritic stimuli. This information is modulated by local neuronal circuits before being 
transmitted by projection neurons to the brain, where it contributes to conscious perception. We still 
have only a limited understanding of sensory processing in the dorsal horn, and this is largely due to 
the very complex organisation of its constituent neurons and the synaptic circuits to which they 
contribute [5,22,78].  
The great majority of neurons in laminae I-II are interneurons, with axonal projections that 
remain within the spinal cord, and these can be divided into two broad functional classes: excitatory 
(glutamatergic) neurons, and inhibitory neurons that use GABA and/or glycine as their principal 
transmitter [5,70,78,91,93]. Anatomical and electrophysiological studies have revealed that there is 
considerable heterogeneity within both of these classes, and there have therefore been numerous 
attempts to define functional populations among both the excitatory and inhibitory populations. 
However, although certain morphological classes can be recognised among these cells [23,89], 
many of them cannot be classified based solely on the basis of somatodendritic morphology 
[20,36,91]. An alternative approach is to use neurochemical markers. We have identified four 
largely non-overlapping neurochemical populations that account for over half of the inhibitory 
interneurons in this region, and shown that these differ in their responses to noxious stimuli and 
synaptic connections, as well as in their dependence on transcription factors during development 
[41,64,78]. 
There is less information available concerning the organisation of excitatory interneurons in this 
region, although we recently reported that three non-overlapping populations could be identified by 
their expression of neurotensin, neurokinin B (NKB) and gastrin-releasing peptide (GRP) [26]. 
These cells accounted for nearly 40% of the excitatory neurons in laminae I-II, and all 3 of these 
neuropeptides overlapped extensively with somatostatin, which is expressed by the majority of 
glutamatergic neurons in this region [16,26]. During the course of that study, we found evidence 
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that an additional population of excitatory neurons might be defined by the expression of substance 
P, which is cleaved from a precursor protein, preprotachykinin A (PPTA), coded by the gene Tac1. 
Although in situ hybridisation studies have identified cells with PPTA mRNA in the superficial 
dorsal horn [86,88], the level of substance P in their cell bodies is normally below the threshold for 
detection with immunocytochemistry. Substance P-expressing neurons elsewhere in the CNS have 
been revealed with antibodies against PPTA [19,40], and we therefore tested whether this approach 
could be used to reveal these cells in the dorsal horn. We went on to characterise the cells and test 
their responsiveness to different noxious and pruritic stimuli. Finally, we used a genetically 
modified mouse in which Cre recombinase is inserted into the Tac1 locus (Tac1Cre) to show that 
substance P-expressing neurons can also be revealed by intraspinal injection of adenoassociated 
virus (AAV) coding for a Cre-dependent form of enhanced green fluorescent protein (eGFP). 
  
Methods 
Experiments were approved by the Ethical Review Process Applications Panel of the University 
of Glasgow and were performed in accordance with the UK Animals (Scientific Procedures) Act 
1986.  
 
Characterisation of PPTA-immunoreactive neurons 
Five wild-type C57Bl/6 mice (either sex, 18-27g) and 3 transgenic mice (either sex, 20-31g) in 
which enhanced green fluorescent protein (eGFP) was expressed under control of the gastrin-
releasing peptide (GRP) promoter (GRP-eGFP) [3,27,51,73] were deeply anaesthetised with 
pentobarbitone (30 mg i.p.) and perfused through the left ventricle with 4% formaldehyde in 
phosphate buffer. The GRP-eGFP mice were used to allow identification of GRP-expressing 
neurons, since GRP itself cannot be detected in neuronal cell bodies, and it has been shown that 
over 90% of eGFP-positive cells in this line have detectable GRP mRNA [73]. 
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Spinal cord segments L3-L5 were post-fixed for 2 hours and cut into transverse sections 60 µm 
thick with a vibrating blade microtome (Leica VT1200 or VT1000S). The sections were processed 
for immunocytochemistry as described previously [20]. They were incubated in primary antibodies 
for 3 days and in secondary antibodies for 1 day, in both cases at 4°C. All antibodies were diluted in 
PBS that contained 0.3% Triton-X100. Details of the sources and concentrations of primary 
antibodies are shown in Table 1. Species-specific secondary antibodies (Jackson Immunoresearch, 
West Grove, PA, USA) were raised in donkey and conjugated to Alexa 488, Rhodamine Red, Alexa 
647, Pacific Blue or biotin. In all cases, the PPTA antibody was detected with a biotinylated 
secondary antibody and revealed with a tyramide signal amplification (TSA) method (TSA kit 
tetramethylrhodamine NL702, PerkinElmer Life Sciences, Boston, MA, USA) as described 
previously [26]. In some cases sections were incubated in DAPI to reveal cell nuclei. Sections were 
then mounted in anti-fade medium and stored at -20°C. They were scanned with a Zeiss LSM710 
confocal microscope equipped with Argon multi-line, 405nm diode, 561nm solid state and 633nm 
HeNe lasers. Scans were obtained through 40× or 63× oil-immersion lenses (numerical apertures 
1.3 and 1.4, respectively), with the confocal aperture set to 1 Airy unit or less. 
Sections from wild-type mice that had been reacted to reveal PPTA, substance P and NeuN were 
initially examined to reveal the relationship between substance P and PPTA and to establish 
whether PPTA could be detected in neuronal cell bodies.  
Sections from 3 wild-type mice that had been reacted with PPTA, Pax2 and NeuN antibodies and 
incubated in DAPI were then were used to determine the proportion of neurons in laminae I-III that 
contained PPTA, and whether any of these expressed Pax2, which is a marker for inhibitory 
interneurons [11,18,41]. Two sections from each mouse were selected for analysis, and one side 
was scanned to generate z-stacks of 25-35 optical sections at 1 µm z-spacing, covering the entire 
cross-sectional area of laminae I-III. These were analysed with Neurolucida for Confocal software 
(MBF Bioscience, Williston, VT, USA). We used a modification of the optical disector method [74] 
described previously [26,63], to obtain an unbiased sample of neurons in laminae I-II and lamina 
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III. The borders between laminae II/III and III/IV were identified by the relatively low packing 
densities of neurons in the inner half of lamina II (IIi) [82] and in lamina IV [26]. The distance 
between reference and look-up sections for the disector sample was between 10-15 µm. Neuronal 
nuclei (defined by the presence of NeuN and DAPI staining) with their bottom surface between the 
reference and look-up sections were selected and plotted onto an outline of the dorsal horn. In all 
cases, we examined all optical sections between the reference and look-up, and added the locations 
of any cells that were entirely contained between these two optical sections [26]. The channels 
corresponding to PPTA and Pax2 were then viewed, and the presence or absence of each type of 
immunoreactivity was noted for the selected neurons. In this way, we determined the proportion of 
all neurons in laminae I-II and in lamina III that were PPTA- and/or Pax2-immunoreactive.  
Since we found that some PPTA-expressing cells were Pax2-positive, and were therefore 
inhibitory interneurons, we looked for evidence that substance P could be detected in axon 
terminals that expressed the vesicular GABA transporter (VGAT). This was achieved by scanning 
sections from 3 wild-type mice that had been reacted with a combination of antibodies against 
substance P, CGRP, VGAT and the vesicular glutamate transporter 2 (VGLUT2). The VGLUT2 
and CGRP antibodies were included, to allow identification of axons belonging to excitatory 
interneurons (which show strong VGLUT2-immunoreactivity), as well as substance P-containing 
primary afferents (which also express CGRP) [39,45,55,83]. 
We next investigated the relationship of PPTA to other markers that define neurochemical 
populations of excitatory interneurons [26]: somatostatin, PKCγ, neurotensin and GRP. For this 
analysis, sections from wild-type or GRP-eGFP mice were reacted with the following antibody 
combinations: (1) PPTA, somatostatin, NeuN; (2) PPTA, PKCγ, Pax2 and NeuN; (3) PPTA, 
neurotensin, PKCγ and NeuN; and (4) PPTA, GFP and NeuN (this reaction was performed on 
sections from GRP-eGFP mice). In each case, tissue from 3 mice was reacted and analysed. For the 
first combination (PPTA, somatostatin, NeuN) we selected 2 sections from each mouse and these 
were scanned with the confocal microscope and analysed using the disector method, as described 
AC
CE
PT
ED
6 
 
above. In the cases of PKCγ, neurotensin and GRP-EGFP, we found that none, or very few, of the 
PPTA cells were included in these populations, and we therefore counted sections in confocal z-
stacks without using a stereological method. 
We could not test directly for co-localisation of PPTA and preprotachykinin B (PPTB, the 
precursor for neurokinin B, NKB), since the antibodies that we have against both of these 
tachykinin precursors were raised in guinea pig [62]. We therefore used an indirect approach, by 
looking for co-localisation in axon terminals derived from these cells. We had previously noted that 
very few VGLUT2-containing (glutamatergic) boutons in the superficial dorsal horn were 
immunoreactive for both substance P and PPTB [27], suggesting that PPTA and PPTB are 
expressed by largely non-overlapping populations. To provide quantitative information, we re-
examined sections used in that study [27]. These were from GRP-eGFP mice, and had been reacted 
to reveal VGLUT2, substance P, PPTB and eGFP (as shown in Fig 10 of reference [27]). Two 
sections each from two mice were scanned to generate z-stacks through laminae I–II, and the dorsal 
part of lamina III. These were analysed with Neurolucida for Confocal. Initially, the channel 
corresponding to PPTB was switched off, and 50 substance P-immunoreactive boutons with high 
levels of VGLUT2 were selected, as these are likely to correspond to axons of substance P-
expressing glutamatergic dorsal horn neurons [79]. Boutons were selected throughout the dorso-
ventral extent of the region scanned. The PPTB channel was then switched on, and the presence or 
absence of PPTB immunostaining was noted for each selected bouton. Each section was then re-
analysed by selecting 50 boutons that were PPTB- and VGLUT2-immunoreactive, then revealing 
the substance P channel and noting the presence or absence of staining in each bouton. 
 
Responses of PPTA-expressing cells to noxious and pruritic stimulation 
Nineteen C57Bl/6 mice of either sex (18-29 g) received either a noxious or a pruritic stimulus 
prior to perfusion fixation, and tissue from these animals was used to test for expression of the 
transcription factor Fos [35], or phosphorylation of extracellular signal-regulated kinases (ERK) 
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[38], in PPTA-immunoreactive cells. Most of the stimuli were applied while mice were under brief 
isoflurane anaesthesia, and they were then allowed to recover for the remainder of the 2 hour 
survival period. The following stimuli were applied in this way: (1) noxious heat (immersion of the 
hindpaw in water at 52°C for 15 seconds (n=3 mice), (2) intraplantar injection of 10 µl of 0.125% 
capsaicin [64] (n=4), (3) intradermal injection of histamine (100 µg in 10 µl PB) into the calf (n=4), 
or (4) intradermal injection of chloroquine (50 µg in 10 µl PB) into the calf (n=4). In all cases, 
stimuli were applied to the left hindlimb. For the animals that received histamine or chloroquine, 
the skin over the calf was shaved on the day before stimulation, and Elizabethan collars were 
applied at the time of shaving and left on for the duration of the experiment to prevent the animals 
from scratching or biting the injected areas [3]. The mice were re-anaesthetised with pentobarbitone 
and perfused with fixative (as described above) two hours after the stimulus. Fewer mice (n=3) 
were tested with the noxious heat because this stimulus resulted in considerably more Fos cells per 
section than the other stimuli. 
In the case of noxious mechanical stimulation, we have found that immunostaining for 
phosphorylated ERK (pERK) is more reliable than Fos immunocytochemistry for detecting 
activated cells [36,64].  pERK appears very rapidly after noxious stimulation [36], and these 
experiments were therefore performed under terminal general anaesthesia. Four mice were 
anaesthetised with 10% urethane i.p. and skin on the lateral aspect of the left calf was pinched with 
forceps at 5 separate locations for 5 seconds each. The mice were perfused with fixative five 
minutes after the last stimulus.  
Transverse sections through the L3 or L4 segments of these mice were reacted to reveal PPTA, 
Pax2 and NeuN, together with either Fos or pERK. Between 4-8 sections that contained numerous 
Fos- or pERK-positive neurons were identified from each experiment and scanned through the 40× 
lens with 1 or 2 µm z-separation to include the mediolateral extent of the area in which Fos- or 
pERK-positive cells were present [3]. The resulting z-stacks were analysed with Neurolucida using 
the modified disector method described above. We initially drew parallel lines at right angles to the 
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laminar boundaries to define the region of superficial dorsal horn that contained a high density of 
Fos or pERK cells as described previously [3]. We then examined the channel corresponding to 
NeuN and identified all neurons in laminae I-II that were between these two lines and had their 
lower surface between the reference and look-up sections. The remaining channels were then 
viewed, and for each of the selected neurons, we determined whether they were immunoreactive for 
PPTA, Pax2 and either Fos or pERK.   
We have previously reported that intradermal injection of vehicle into the calf does not result in 
significant Fos labelling in the dorsal horn [3], and we have found that this is also the case for 
intraplantar injection of vehicle (EP, AJT unpublished observations). 
 
Injection of Cre-dependent reporter virus into the Tac1Cre mouse 
In order to verify the expression of PPTA with an independent approach, we used mice in which 
Cre recombinase was knocked into the Tac1 locus [29] (Tac1-IRES2-Cre-D; The Jackson 
Laboratory, Bar Harbor, ME USA; Stock number 021877). These mice, referred to as Tac1Cre, were 
bred with a reporter line Ai9 (Jackson Laboratory; Stock number 007909), in which Cre-mediated 
excision of a STOP cassette drives expression of the red fluorescent protein tdTomato (tdTom). The 
resulting offspring (Tac1Cre;Ai9) should have tdTom in all neurons that have expressed Tac1 at any 
stage during development. Two adult female Tac1Cre;Ai9 mice (18, 20g) were anaesthetised with 
isoflurane and received intraspinal injections of an adenoassociated virus (AAV, serotype 1) coding 
for a Cre-dependent form of eGFP (AAV.flex.eGFP; Penn Vector Core, Philadelphia, PA, USA). 
This virus encodes an inverted sequence for eGFP between pairs of heterotypic LoxP sites with 
anti-parallel orientation [2]. In infected cells that express Cre at the time of injection, there will be 
permanent reversal of the coding sequence, resulting in expression of eGFP. Injections were made 
at two sites in the dorsal horn, based on the method described by Foster et al [18]. The vertebrae 
T12 and L1 were identified and clamped with spinal adaptors attached to a stereotaxic frame. A 
small slit was made in the dura on either side of the T13 vertebra and injections were made through 
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a glass micropipette (tip diameter 40 µm) into the dorsal horn on the right side at a depth of 300 µm 
below the dorsal surface. A volume of 300 nl (containing 1.72 x 109 gene copies) was made at each 
injection site a rate of 30 nl/min. The wound was closed, and animals were allowed to recover with 
appropriate analgesia. After an 8 day survival period, they were re-anaesthetised and perfused with 
fixative as described above. The rationale for this approach is that among neurons infected by 
AAV.flex.eGFP in the region of the injection site, those that continue to express PPTA should 
generate eGFP, and will therefore contain both fluorescent proteins. In contrast, neurons that 
expressed PPTA only transiently during earlier development, will synthesise tdTom but not eGFP. 
Transverse sections from the L3 segment were cut into 3 bottles, which were processed for 
immunocytochemistry as follows: (1) anti-mCherry and chicken anti-NeuN; (2) Pax2 and PKCγ; (3) 
PPTA. The anti-mCherry, which also detects tdTom, was used in the first reaction to amplify the 
tdTom signal and these sections were subsequently stained with DAPI. The chicken (rather than the 
mouse) NeuN antibody was used in this case because we have found that immunoreactions 
involving mouse antibodies show high background staining in animals that have received 
intraspinal injections, presumably due to the local immune response. In the third reaction, the PPTA 
was revealed with a TSA method involving the far-red dye Cy5 (TSA kit NL705, PerkinElmer Life 
Sciences).  
In order to determine the proportions of neurons that contained tdTom and eGFP, we selected 3 
sections per mouse from the first reaction (mCherry, NeuN, DAPI) that had numerous eGFP+ cells. 
These were scanned through the 40× lens to include the area containing the eGFP cells. Z-stacks (1 
µm separation) were acquired and analysed with the disector method as described above. The 
distance between reference and look-up sections was 10 µm. Neurons in laminae I-II for which the 
bottom surface of the nucleus was included in the disector were first identified. The channels 
corresponding to eGFP and tdTom were then viewed and the presence or absence of each 
fluorescent protein in the selected neurons was recorded.  
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During the analysis of PPTA-immunoreactive neurons we found that these included some Pax2-
positive (inhibitory) neurons, but that they were very seldom immunoreactive for PKCγ, which is 
expressed by a distinct subset of excitatory interneurons [26,61]. We therefore analysed two 
sections from the second antibody combination (Pax2 and PKCγ) from each mouse. These were 
scanned with the 40× lens (1 µm z-separation) through the full thickness of the section to include 
the region that contained eGFP cells. The resulting z-stacks were analysed with Neurolucida, and all 
neurons that contained either eGFP or tdTom were identified. The channels corresponding to Pax2 
and PKCγ were then viewed, and the presence or absence of each type of staining was recorded for 
the selected cells. Although a stereological technique was not used for this analysis, the error due to 
oversampling of cells at the section surfaces [24] is likely to be small, since the section thickness 
(60 µm) was much greater than the typical diameter of these neurons. 
To test for the presence of PPTA in cells that were either tdTom- or tdTom/eGFP-labelled, 2 or 3 
sections per mouse that contained numerous eGFP cells were selected from the third 
immunoreaction. These were scanned through the 40× lens with a 1 µm z-separation. Initially, the 
channels corresponding to tdTom and PPTA-immunoreactivity were viewed. From each animal, 50 
TdTom+ cells that were PPTA-immunoreactive were identified. The eGFP channel was then 
viewed, and the presence or absence of eGFP was recorded for each selected cell. 
 
Antibody characterisation 
The PPTA antibody was raised against a sequence of 15 amino acids (residues 98-112 of α-
preprotachkinin A) and recognises PPTA, but not substance P or neurokinin A [44]. The 
monoclonal substance P antibody detects the C-terminal 5-8 amino acids of substance P, and does 
not appear to recognise neurokinin B [13,50,62]. The monoclonal NeuN antibody was raised against 
cell nuclei extracted from mouse brain and reacts with a protein specific for neurons [53], which 
was subsequently identified as the splicing factor Fox-3 [42]. The chicken NeuN antibody was 
raised against a recombinant protein corresponding to amino acids 1-97 of mouse Fox-3. The 
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antibody against Pax2 was raised against amino acids 188-385 of the mouse protein. The VGLUT2  
and VGAT antibodies were raised against amino acids 510-582 of rat VGLUT2 and amino acids 
31-112 of mouse VGAT, respectively, and both detect single protein bands of the appropriate 
molecular weight [52,77]. The CGRP antibody detects both α and β forms of the peptide 
(manufacturer's specification). The PKCγ antibody was raised against amino acids 684-697 of the 
mouse protein and detects a single band at 75 kDa [57]. The somatostatin antibody is reported to 
show 100% cross-reactivity with somatostatin-28 and somatostatin-25, but none with substance P or 
neuropeptide Y, and staining is blocked by preincubation with somatostatin [66]. Staining with the 
rat anti-neurotensin is identical to that seen with a well-characterised rabbit antibody, and is blocked 
by pre-incubation with the peptide [65]. The eGFP antibodies were raised against recombinant full-
length eGFP, and their staining matches that of native eGFP fluorescence. The mCherry antibody 
was raised against full length recombinant protein, and also recognises tdTomato. The Fos antibody 
was raised against a peptide corresponding to the N-terminus of human Fos, while the pERK 
antibody is specific for ERK1 and ERK2 that are dually phosphorylated at Thr202 and Tyr204 sites. 
Specificity of the Fos and pERK antibodies was shown by the restriction of staining to neurons in 
somatotopically appropriate areas, following noxious or pruritic stimulation. 
 
Statistics 
Data were formatted into two individual 2 × 2 contingency tables for each of the animals that 
received noxious or pruritic stimulation, with rows corresponding to presence or absence of eGFP 
or Pax2 and columns to presence or absence of Fos or pERK. To determine whether there was a 
consistent difference in the proportions across the animals for the different cell populations, we 
used the Mantel–Haenszel analysis [3]. In all cases, Breslow-Day testing was performed to test the 
assumption that the odds ratio was the same across animals [3]. 
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Results 
PPTA-expressing neurons and their neurotransmitter phenotype 
Immunostaining for PPTA was concentrated in the superficial laminae (I-II) and present at lower 
levels in the deeper parts of the dorsal horn. In sections reacted with antibodies against PPTA and 
substance P, PPTA staining was seen in small profiles scattered through the neuropil and these were 
frequently also substance P-immunoreactive (Fig 1a,b). PPTA was also detected in the cell bodies 
of certain neurons, which were identified by the presence of NeuN (Fig 1c). This cell body labelling 
with the PPTA antibody was restricted to the perikaryal cytoplasm, and was never co-localised with 
substance P-immunoreactivity. The small profiles that were both PPTA- and SP-immunoreactive 
are likely to be axon terminals, while the cytoplasmic staining presumably corresponds to PPTA in 
the endoplasmic reticulum and/or Golgi apparatus of PPTA-expressing neurons. Neurons 
containing PPTA were present throughout laminae I-III and were occasionally seen in deeper 
laminae. The axonal staining for PPTA was generally restricted to the superficial parts of the 
sections, presumably due to the limited penetration of antibodies in fine axonal processes. In 
contrast, the cell body labelling was present throughout the depth of the sections, and there was no 
obvious difference in the frequency of immunoreactive neurons at different depths in the section. 
Quantitative analysis revealed that PPTA-immunoreactive cells accounted for 14% of the 
neurons in laminae I-II and 4% of those in lamina III (Table 2). In sections that had been stained for 
PPTA and Pax2, we found that although the majority of PPTA+ neurons were Pax2-negative, there 
were also PPTA+/Pax2+ cells scattered throughout laminae I-III (Fig 2), indicating that some of the 
PPTA-expressing cells were inhibitory interneurons. Pax2-immunoreactivity was observed in 
around 19% of the PPTA+ neurons in laminae I-II and in 21% of those in lamina III (Table 2). The 
proportions of all neurons that were Pax2 in these sections were 25% for laminae I-II and 40% for 
lamina III, and these values are very close to our previous estimates of the proportion of neurons in 
these regions that are GABA and/or glycine-immunoreactive in the mouse spinal cord (25.8% for 
laminae I-II and 37.6% for lamina III) [60]. This provides further support for the suggestion that 
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immunostaining for Pax2 reveals virtually all inhibitory interneurons in this region [18,41]. Since 
the remaining neurons (74.2% of those in laminae I-II and 62.4% of those in lamina III) are 
presumably glutamatergic [60], the present results suggest that PPTA-immunoreactive neurons 
account for ~15% of glutamatergic (excitatory) neurons in laminae I-II and 5% of those in lamina 
III (Table 2). 
Substance P-containing axons in the dorsal horn are thought to originate predominantly from two 
sources: primary afferents (in which substance P is co-localised with CGRP [39,45,83]), and local 
neurons. We have previously reported that in the rat all substance P-containing axonal boutons that 
lacked CGRP were VGLUT2-immunoreactive [79], which would suggest that substance P (and 
therefore PPTA) was only expressed by glutamatergic dorsal horn neurons. We were therefore 
surprised to find that significant numbers of PPTA-immunoreactive neurons in laminae I-III were 
Pax2-positive (inhibitory). To test whether this discrepancy resulted from a species difference, we 
examined sections of mouse spinal cord that had been reacted with antibodies against substance P, 
CGRP, VGLUT2 and VGAT. We found that, as in the rat, boutons with strong substance P 
immunoreactivity were invariably either CGRP-immunoreactive (with weak or undetectable levels 
of VGLUT2 [79]), or showed strong VGLUT2-immunostaining and were CGRP-negative. 
However, in each of laminae I-III we occasionally observed extremely weak staining for substance 
P in VGAT-immunoreactive boutons (Fig 3). This suggests that although PPTA is present in some 
inhibitory interneurons in these laminae, the level of substance P in their axon terminals is very low. 
 
Relation of PPTA-expressing excitatory neurons to other subpopulations 
In the sections reacted with antibodies against PPTA, somatostatin and NeuN, we analysed cells 
in laminae I-II, since somatostatin is virtually restricted to excitatory (glutamatergic) neurons in this 
region, whereas the peptide is expressed by both inhibitory and excitatory interneurons in lamina III 
[16,66,87,88]. Between 370-596 neurons in laminae I-II were analysed in the 3 mice. Within this 
sample 13.2% (range 12.4-14%) were PPTA-immunoreactive, while 44.8% (42.5-46.6%) were 
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immunoreactive for somatostatin. Many cells containing both types of immunoreactivity were 
observed (Fig 4a-c), and these accounted for 57.4% (range 54.9-62.2%) of the PPTA-positive 
neurons. Since 19% of PPTA-positive neurons in this region are Pax2+ (inhibitory), and 
somatostatin is restricted to excitatory neurons in this region, we estimate that 71% of the PPTA+ 
excitatory neurons are somatostatin-immunoreactive.  
In the sections from the 3 GRP-eGFP mice, we identified a mean of 151 (range 109-219) eGFP-
positive cells and 155 (range 111-196) PPTA-immunoreactive cells in laminae I-III, and found that 
none of these were double-labelled (Fig. 4d-f). 
In sections reacted with PPTA, PKCγ and Pax2 antibodies, we identified between 109-132 
(mean 117) PKCγ+ cells and between 39-44 PPTA+/Pax2-negative cells (mean 41.7) in laminae I-III 
(n = 3 mice). Although there was some overlap in the distribution of these two populations in the 
laminae IIi-III,  none of them were double-labelled. We have previously shown that 90% of 
neurotensin-expressing cells are PKCγ+ [26], and would therefore not express PPTA. For this 
reason, we examined neurotensin-immunoreactive cells that lacked PKCγ in the sections that had 
been reacted with PPTA, neurotensin, PKCγ and NeuN antibodies. We identified 61 of these cells 
(17-26 in each mouse), and found that only one of them was PPTA-immunoreactive. An example of 
PPTA staining in a section reacted for PPTA, neurotensin and PKCγ is shown in Fig 4g-i. 
In the sections that had been reacted for PPTB, substance P and VGLUT2 [27] we found  
minimal coexistence of PPTB and substance P in VGLUT2-immunoreactive boutons. The vast 
majority (98.5%, range 98-99%) of the selected substance P-immunoreactive boutons were negative 
for PPTB, while the same proportion (range 97-100%) of PPTB-immunoreactive boutons lacked 
staining for substance P. 
Taken together, these results indicate that PPTA is not expressed to a significant extent in 
excitatory interneurons that express GRP, NKB, neurotensin or PKCγ. However, it overlaps 
extensively with somatostatin, such that the majority (~70%) of PPTA-positive cells contain 
somatostatin. 
AC
CE
PT
ED
15 
 
 
Expression of Fos and pERK after noxious or pruritic stimulation 
Following noxious heat or the injection of capsaicin or pruritogens (chloroquine, histamine), 
Fos-positive cells were seen in the ipsilateral dorsal horn. Their distribution was similar to that 
reported previously in the mouse in response to these stimuli [1,3,4,9,28,49,94], and examples from 
mice stimulated with noxious heat, capsaicin and histamine are shown in Fig 5q-s. We have 
previously illustrated the distribution of Fos cells in mice treated with chloroquine [3]. Fos+ cells 
were located mainly in the superficial laminae, with a rostrocaudal and mediolateral distribution 
that corresponded to the somatotopic location of the stimulus [3]. Very few, if any, Fos cells were 
present on the contralateral side (Fig 5t). 
Pax2 antibody was included in the immunoreaction for this part of the study so that we could 
identify the excitatory (Pax2-negative) PPTA-immunoreactive neurons. However, we also took the 
opportunity to determine the proportion of Pax2-positive and Pax2-negative cells among the 
neurons that were Fos-immunoreactive after each stimulus (Fig 5, Table 3). In the experiments 
involving noxious heat, the proportion of Pax2-positive cells with Fos (51%) was significantly 
higher than the proportion of Pax2-negative cells (37%) (p<0.001, Mantel–Haenszel test). For the 
other stimuli, the proportions of excitatory and inhibitory neurons that were Fos-immunoreactive 
did not differ significantly.  
We then determined the proportion of excitatory (Pax2-negative) PPTA cells with Fos and 
compared this to the proportion of all Pax2-negative cells that were Fos-immunoreactive for each 
stimulus (Table 4). For all of the stimuli tested, some of the excitatory PPTA cells were Fos-
immunoreactive (Fig 5). The proportions of excitatory PPTA cells with Fos varied between ~30-
40% for noxious heat and the two pruritogens, but was considerably lower for capsaicin (9%). 
When we compared these values to the proportions of all excitatory neurons in laminae I-II that 
showed Fos, we found that they differed significantly for the mice that had been injected with 
capsaicin or histamine. In the capsaicin-injected mice PPTA cells were significantly under-
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represented (9% Fos-immunoreactive) compared to all excitatory neurons (23% Fos-
immunoreactive) (p<0.005, Mantel–Haenszel Test). In contrast, PPTA cells were over-represented 
among the excitatory neurons that were Fos-immunoreactive after histamine (38% for PPTA cells, 
25% for all excitatory neurons; p<0.001, Mantel–Haenszel Test). 
Following pinching of the skin, the distribution of pERK+ cells was similar to that described 
previously [36,72]. The proportions of Pax2+ and Pax2- that were pERK-immunoreactive within the 
activated region were 46% and 36% respectively (Table 3), and this differed significantly (p<0.005, 
Mantel–Haenszel Test). Among the excitatory PPTA cells, 47% were pERK-immunoreactive (Fig 
6, Table 4), although the difference between this proportion and the proportion of all excitatory 
neurons with pERK did not reach significance. 
Together, these results show that inhibitory neurons in laminae I-II were more likely than 
excitatory neurons to show Fos or pERK following the noxious mechanical or heat stimuli, and that 
among the excitatory neurons, PPTA cells were over-represented following histamine, but under-
represented after capsaicin. It should be noted that neurons may respond to these stimuli without 
expressing Fos or phosphorylating ERK, and therefore the numbers of cells revealed with these 
markers are almost certainly an underestimate of the numbers activated. However, these results 
suggest that the PPTA cells were more effectively activated by histamine, and less by capsaicin, 
than other excitatory neurons in this region. 
 
Injection of AAV.flex.eGFP into Tac1Cre;Ai9 mice  
TdTom-positive cells were present throughout the dorsal horn in the Tac1Cre;Ai9 mice, with the 
highest concentration in the superficial laminae (Fig 7a). Injection of AAV.flex.eGFP resulted in 
widespread expression of eGFP at the segmental level of the injection sites. eGFP-positive cells 
were  particularly numerous in the outer part of lamina II (IIo), with a few cells in lamina I or 
scattered through the deeper dorsal horn (Fig 7b). The eGFP cells were present in the medial half to 
two-thirds of the dorsal horn, and this distribution presumably reflects the location of the injection 
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sites. Some of the eGFP+ cells in lamina III had dendrites that extended dorsally into the superficial 
region (Fig 7b), resembling anterolateral tract projection neurons [7,55,80]. Primary dendrites of the 
eGFP cells in lamina II often emerged from the ventral aspect of the soma (Fig 7b inset), although 
these could not be followed far because of the density of eGFP-labelled profiles in this region. The 
total numbers of lamina I-II neurons analysed in the disector sample for the two mice were 184 and 
329, and 28% of these (27.1% and 28.8%, respectively) were tdTom+. Within the zone occupied by 
GFP+ cells, these accounted for 19.6% (21.2%, 17.9%) of all lamina I-II neurons, and virtually all 
of these (96%) were also tdTom+ (Figs 8, 9). Within this region, eGFP was therefore detected in 
~70% of the tdTom+ neurons.  
In sections stained for PKCγ and Pax2, we noted that the band of eGFP+ neurons lay dorsal to 
that of the PKCγ cells, and that although many of the PKCγ cells were labelled with tdTom, they 
were very seldom eGFP+ (Fig 7b,c). Quantitative analysis confirmed this, since we found that only 
9 out of 363 eGFP cells examined (2.5%) were PKCγ-immunoreactive. In fact, 6 of these cells were 
Pax2-positive, and therefore only 3/363 (0.8%) of the eGFP+ cells belonged to the excitatory (Pax2-
negative) PKCγ population (Table 5). This is consistent with the lack of co-localisation between 
PPTA- and PKCγ-immunoreactivities, described above. In contrast, 44% of the tdTom+ cells that 
lacked eGFP were PKCγ neurons (Fig 7c, Table 5). Also, consistent with the finding that some 
PPTA-immunoreactive neurons are Pax2+, we found that 11% of eGFP+ cells were Pax2-
immunoreactive, as were 9% of eGFP-/tdTom+ cells (Fig 8, Table 5).  
In the sections immunostained for PPTA we identified 100 PPTA-immunoreactive tdTom+ cells, 
and all but one of these (99%) was positive for eGFP (Fig 9).  
Based on the proportion of neurons in laminae I-II that were eGFP+ (~20%) and the finding that 
90% of these were Pax2-negative, we estimate that the eGFP+ excitatory cells account for 18% of 
all neurons in laminae I-II. We have previously estimated that excitatory neurons make up 74.2% of 
the total neuronal population in these laminae [60], and therefore the eGFP+ cells would correspond 
to  ~24% of these excitatory neurons. The difference between this value and the ~15% of excitatory 
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neurons that are PPTA-immunoreactive (see above) could result from a low level of somatic PPTA 
in some cells, meaning that immunocytochemistry for PPTA underestimates the proportion of 
excitatory neurons that express PPTA and therefore release substance P. Alternatively, some of the 
cells with eGFP may fail to produce significant amounts of PPTA, for example due to degradation 
of the mRNA [84]. In either case, it is likely that the proportion of excitatory neurons in laminae I-II 
that express PPTA and release substance P is between 15-24%. 
 
Discussion 
The main findings of this study are that: (1) PPTA can be detected in ~20% of neurons in lamina 
I-II, most of which are Pax2-negative, and so presumably excitatory; (2) these are quite distinct 
from populations defined by expression of GRP, neurotensin, NKB or PKCγ, but many of them 
contain somatostatin; (3) many of the excitatory PPTA cells respond to noxious or pruritic stimuli; 
and (4) this population can also be detected by intraspinal injection of AAV.flex.eGFP in adult 
Tac1Cre mice. 
 
Substance P-expressing dorsal horn neurons 
Several immunocytochemical studies have identified substance P-containing neurons in laminae 
I-II with a distribution similar to that reported here for PPTA [33,34,43,54,68,71,92]. However, in 
these studies colchicine was used to increase the concentration of peptide in the cell bodies, and this 
approach has the potential problem that colchicine may alter mRNA levels, and even result in de 
novo synthesis of neuropeptides [12,67]. A recent in situ hybridisation study [88] identified a "late 
wave" of Tac1 mRNA neurons in laminae I-II that were dependent on expression of the 
transcription factor Tlx3, which determines glutamatergic fate [11]. These cells were thought to 
originate from the dILB population of late-born excitatory interneurons [31], which also gives rise to 
several other neurochemically-defined classes in the superficial laminae, including neurons that 
express PKCγ, somatostatin, neurotensin, NKB, GRP and the GRP receptor (GRPR) [87,88]. An 
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advantage of using the PPTA antibody is the greater versatility of immunocytochemistry compared 
to in situ hybridisation, for example the possibility of multiple-labelling, which allows detailed 
characterisation of the cells. 
Excitatory interneurons arising from the DILB population are neurochemically heterogeneous 
[6,25,88]. Our previous studies [26,27], together with the present results, demonstrate a complex 
pattern of intersection of neurochemical markers. Four neuropeptides (substance P, GRP, 
neurotensin and NKB) are expressed in largely non-overlapping populations, with the neurotensin- 
and NKB-expressing cells being mainly included among the PKCγ neurons in lamina IIi. We 
previously estimated that GRP and NKB cells each made up ~15% of the excitatory neurons in 
laminae I-II, and neurotensin cells a further 8% [26]. The present results suggest that substance P-
expressing neurons account for between 15-24% of the excitatory neurons, meaning that together 
these four populations account for over half of the glutamatergic neurons in the superficial laminae. 
In contrast, somatostatin is widely expressed among the excitatory neurons and overlaps extensively 
with each of these neuropeptides.  
The finding that some PPTA-immunoreactive cells were Pax2+, and therefore presumably 
inhibitory interneurons, was surprising for two reasons. Firstly, it has been reported that superficial 
dorsal horn cells with Tac1 mRNA are lost in Tlx3-mutant mice [88], and secondly, we found in the 
rat that all non-primary substance P-immunoreactive axon terminals were VGLUT2-
immunoreactive [79]. Consistent with our findings in rat, we saw only very low levels of substance 
P in a few inhibitory (VGAT-immunoreactive) boutons in the mouse. However, our interpretation 
that some inhibitory interneurons express PPTA was supported by the finding of Pax2-positive 
eGFP cells in the Tac1Cre;Ai9 mice that had been injected with AAV.flex.eGFP. It is therefore 
likely that some inhibitory interneurons express PPTA and but do not have significant quantities of 
substance P in their axon terminals. This could result from failure to cleave the active peptide from 
the precursor, failure to transport it to the axon terminal, or its rapid degradation [84]. 
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Functional role of substance P-expressing excitatory interneurons in laminae I-II 
Recent studies of mice in which subsets of excitatory interneurons in the superficial dorsal horn 
have either failed to develop [85,88] or have been ablated [16] indicate that these cells play a 
critical role in perception of both pain and itch. Our finding that the PPTA-expressing excitatory 
cells include many that respond to noxious or pruritic stimuli suggests that loss of these cells 
contributed to the reduction in pain and itch behaviours seen in these studies. Among the other 
neurochemical types of excitatory interneuron, those expressing neurotensin and NKB are located 
in laminae IIi and III, and correspond largely to the PKCγ cells [26]. They are therefore unlikely to 
respond to noxious or pruritic stimuli [56]. We have shown that the GRP cells seldom show Fos or 
pERK after injection of chloroquine [3], and we find that they rarely have Fos or pERK after other 
noxious or pruritic stimuli (AMB and AJT, unpublished observations). Interestingly, although many 
PPTA+ cells responded to noxious thermal and mechanical stimuli, they were significantly under-
represented among those that showed Fos after injection of capsaicin, even though TRPV1 plays an 
important role in detection of noxious heat. This suggests that they may be preferentially innervated 
by nociceptors that lack the capsaicin receptor TRPV1, and these could include non-peptidergic C 
fibres that express the mas-related G protein-coupled receptor MrgD [10,95] as well as myelinated 
afferents [69]. 
Mice lacking substance P or its receptor (the neurokinin 1 receptor, NK1r) show exaggerated 
pain [8,15], suggesting a role for substance P in nociceptive processing. However, since ~80% of 
substance P in the dorsal horn originates from primary afferents [37], the contribution of peptide 
released by spinal neurons cannot yet be determined. Recent studies indicate that different 
populations of inhibitory interneurons are responsible for suppression of itch and pain [41,59], but 
much less is known about the roles of excitatory interneuron populations. Our finding that many 
PPTA neurons were activated by noxious and pruritic stimuli could result from convergence of 
input onto these cells, but it is possible that different subsets are involved in transmitting itch and 
pain, and further studies will be needed to address this. Another important issue is the relation of the 
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PPTA cells to those that express GRPR, which are also dependent on Tlx3 [88], and which have 
been implicated in spinal itch pathways [51,75,76].  
Although the morphology of these cells is not yet known, the finding that many eGFP+ cells in 
the injected Tac1Cre;Ai9 mice had ventrally-directed primary dendrites raises the possibility that 
they correspond to vertical cells [23]. Vertical cells (also known as stalked cells [21]) form a well-
defined morphological class of excitatory interneuron, which are most numerous in lamina IIo, and 
have prominent ventrally-directed dendritic trees [23,47,48,81,91]. They are likely to account for a 
relatively large proportion of the excitatory interneurons in this lamina, because in a blind whole-
cell patch-clamp study in the rat, 12 of 33 excitatory interneurons identified could be assigned to 
this class [91]. GRP cells seldom show vertical morphology [27], and neither do PKCγ cells [61] 
(which include most of those expressing neurotensin or NKB), suggesting that vertical cells may 
correspond to a specific neurochemical population. Vertical cells often have axons that enter lamina 
I, and are thought to form part of a polysynaptic pathway that relays nociceptive information to 
projection cells in this lamina [47]. They may also contribute to mechanical allodynia in 
pathological pain states [46,90]. If the PPTA-expressing neurons do correspond to vertical cells, this 
would suggest that they have a dual excitatory action on lamina I anterolateral tract projection 
neurons: firstly through glutamatergic synapses [47], and secondly through substance P acting 
NK1rs, which are expressed by 90% of these cells [7]. 
 
Targeting the substance P-expressing cells in the Tac1Cre mouse line 
To investigate the roles of the substance P-expressing interneurons it will be necessary to 
manipulate their function or ablate them, and these approaches have recently been applied to several 
other populations of dorsal horn neurons [14,16,18,58,59]. The Tac1Cre mouse provides a 
convenient way of doing this, but there are several caveats. Firstly, PPTA is expressed by many 
nociceptive primary afferents, by a small number of superficial inhibitory interneurons, as well as 
by some lamina I and deep dorsal horn neurons that may belong to the anterolateral tract [7]. In 
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addition, comparison of the tdTom and eGFP cells in the injected Tac1Cre mice shows that there is 
expression of tdTom in excitatory neurons that do not appear to express PPTA in the adult, for 
example many of the PKCγ neurons. It is likely that this reflects transient expression of PPTA that 
is switched off during development. Crossing the Tac1Cre mice with other lines that express Cre-
dependent proteins, would therefore result in expression of these proteins beyond the population of 
PPTA-expressing superficial dorsal horn excitatory interneurons. Our finding that the majority of 
these cells also contain somatostatin provides a potential way of targeting them selectively, since 
somatostatin is not co-expressed with substance P in primary afferents [32,45,83] or with NK1r+ 
projection neurons in lamina I [16], and is largely restricted to excitatory interneurons in lamina II 
[16,66]. A mouse line in which another recombinase (Flpo) has been knocked into the somatostatin 
locus has recently been reported [30], and if this is crossed with the Tac1Cre line, expression of both 
Cre and Flpo should be largely restricted to the PPTA-expressing excitatory interneurons in laminae 
I-II. Transient expression by other excitatory interneurons (e.g. those with PKCγ) would still 
represent a problem, but this could be avoided by intraspinal injection of AAVs coding for proteins 
whose expression was dependent on both Cre and Flpo [17]. 
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FIGURE LEGENDS 
Fig 1 Immunostaining for PPTA, substance P (SP) and NeuN in the mouse dorsal horn. (a) 
PPTA-immunoreactivity (magenta) appears as fine punctate structures, many of which are 
axons (three indicated with arrowheads), as well as large clumps (arrows) that represent 
staining in the perikaryal cytoplasm of certain neurons.  (b) SP (green) is co-localised with 
PPTA in the axons, but not in the perikaryal cytoplasm. (c) Staining for the neuron-specific 
protein NeuN confirms that the clumps of PPTA shown with the arrows are in the cell 
bodies of two of the neurons. The solid line indicates the outline of the grey matter and the 
dashed line shows the border between laminae II and III. The images are projected from 2 
optical sections at 1 µm z-spacing. Scale bar = 50 µm. 
Fig 2 The distribution of excitatory and inhibitory PPTA cells. (a) Plot of the distribution of all 
PPTA-immunoreactive cells obtained from the stereological analysis of 3 mice (2 sections 
each) showing the location of Pax2-negative (excitatory) cells as filled circles and Pax2-
positive (inhibitory) cells as open circles. The solid line represents the outline of the grey 
matter, and the upper and lower dashed lines the borders between laminae II-III and III-IV, 
respectively. (b-d) Examples of Pax2-negative and –positive cells seen in confocal images. 
These have been scanned to reveal PPTA (red), Pax2 (green) and NeuN (blue). The arrow 
indicates a PPTA-immunoreactive cell that was Pax2-positive, while the arrowheads show 
2 PPTA-immunoreactive cells that lack Pax2. The images are projections of 3 optical 
sections at 2 µm z-spacing. Scale bar = 20 µm.  
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Fig 3 Immunostaining for substance P, CGRP and vesicular neurotransmitter transporters in 
lamina II of the dorsal horn. a shows a field that contains several Substance P (SP)-
immunoreactive profiles (red). b the same field scanned to reveal vesicular glutamate 
transporter 2 (VG2, blue) and vesicular GABA transporter (VGAT, green). c a merged 
image, showing SP, VG2 and VGAT. d the same field scanned to reveal SP (red) and 
CGRP (blue). Comparison of these images shows that some substance P-immunoreactive 
profiles are strongly labelled for VG2, and are likely to correspond to axons of excitatory 
PPTA-expressing neurons (one indicated with arrow), while others are immunoreactive for 
CGRP and represent central terminals of peptidergic primary afferents (one shown with 
double arrowhead). Occasionally VGAT-positive profiles with very weak SP-
immunoreactivity are present, and one of these is indicated with an arrowhead. All images 
are projections of 3 optical sections at 0.3 µm z-spacing. Scale bar = 5 µm. 
Fig 4 Neurochemical characterisation of PPTA-immunoreactive cells. a-c: Immunostaining for 
PPTA (red), NeuN (blue) and somatostatin (SST, green) reveals neurons with both PPTA 
and somatostatin in their perikaryal cytoplasm (two indicated with arrows), as well as cells 
that are only positive for somatostatin (two marked with asterisks). d-f: A section from a 
GRP-eGFP mouse stained for eGFP (green), PPTA (red) and NeuN (blue). PPTA- 
immunoreactive cells (two shown with arrows) were completely separate from eGFP+ cells 
(3 marked with asterisks). g-i: A section immunostained to reveal PPTA (red), NeuN 
(blue), neurotensin (NT, green) and PKCγ (blue). g has been scanned to reveal PPTA and 
NeuN and shows a cell that is PPTA-immunoreactive (arrow), as well as several that are 
PPTA-negative (one of which is marked with an asterisk). h the same field scanned to 
reveal neurotensin and PKCγ. The cell marked with the arrow is negative for both markers. 
The cell with the asterisk is immunoreactive for both PKCγ (which labels the plasma 
membrane) and neurotensin (which is in the perikaryal cytoplasm). i: A merge of PPTA, 
NeuN and neurotensin confirms that PPTA and neurotensin are in different neurons. 
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Images in a-c are projections of 4 optical sections at 0.5 µm z-spacing; those in d-f are 
projections of 2 optical sections 1 µm apart; those in g-i are projections of 3 optical 
sections at 0.5 µm z-spacing. Scale bar = 10 µm. 
Fig 5 Fos-immunoreactivity following noxious or pruritic stimulation. a-d, e-h, i-l and m-p are 
from mice that were stimulated with noxious heat, capsaicin, histamine or chloroquine, 
respectively. In each case the same field from superficial dorsal horn is shown stained for 
PPTA (red), Fos (blue) and Pax2 (green), together with a merged image. The insets in d, h, 
l and p show staining for PPTA (red) and NeuN (blue) in the marked PPTA-
immunoreactive cells. a-d: the noxious stimulus resulted in numerous Fos+ neurons. This 
field contains two PPTA-immunoreactive/Pax2-negative cells that have Fos-
immunoreactive nuclei (arrows). In addition, a PPTA-negative cell that is positive for both 
Pax2 and Fos is shown with an arrowhead, and a PPTA-positive/Pax2-positive cell that 
lacks Fos is indicated with an asterisk. e-h: relatively few of the PPTA+ excitatory (Pax2-
negative) cells showed Fos after capsaicin injection. This field shows one of these cells 
that lacks Fos (arrow). Two Fos-immunoreactive cells are indicated with arrowheads. The 
one on the left is negative for Pax2, while that on the right is Pax2+. i-l: This field from a 
histamine-injected mouse shows a PPTA+ excitatory (Pax2-negative) cell that contains Fos 
(arrow). In addition, two PPTA-negative cells that are immunoreactive for both Fos and 
Pax2 are indicated (arrowheads). m-p: Following stimulation with chloroquine several 
Fos-immunoreactive neurons are visible, and two of these (marked with arrows) are PPTA-
immunoreactive excitatory (Pax2-negative) neurons. Images are projections of 3 (e-h), 5 
(a-d), or 4 (i-p) optical sections at 1 µm z-spacing. q-s show lower magnification views of 
the ipsilateral dorsal horn from mice treated with noxious heat, capsaicin or histamine (the 
same sections as those in a-l) scanned to reveal Fos. t shows the contralateral side of the 
histamine-treated animal. Scale bars: a-p = 20 µm; q-t = 100 µm. 
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Fig 6 pERK-immunoreactivity following pinch. a-c show immunostaining for PPTA (red), 
pERK (blue) and Pax2 (green) in the superficial dorsal horn of an animal that was 
perfusion fixed 5 minutes after pinching of the calf under urethane anaesthesia, while d 
shows a merged image. Two PPTA-immunoreactive cells that lack Pax2 are pERK-
positive (arrows). Images are projections of 3 optical sections at 1 µm z-spacing. Scale bar 
= 20 µm. 
Fig 7 The distribution of tdTom- and eGFP-positive cells in the dorsal horn following intraspinal 
injection of AAV.flex.eGFP into a Tac1Cre;Ai9 mouse. The section has been scanned to 
reveal tdTom (red), eGFP (green) and PKCγ (blue). (a) TdTom+ neurons are concentrated 
in the superficial laminae and scattered through the deep dorsal horn. (b) The distribution 
of eGFP+ neurons is more restricted, as most of these lie dorsal to the band of neurons 
immunoreactive for PKCγ, which occupy lamina IIi. Note that none of the eGFP+ cells are 
PKCγ-immunoreactive. In addition, two very large eGFP+ neurons (arrows) are located in 
laminae III-IV and both have dendrites that extend into the superficial laminae. The inset 
(corresponding to the box) shows some of the eGFP+ cells at higher magnification, and 
primary dendrites can be seen leaving the ventral surface of the soma in several cases 
(arrowheads). (c) In the merged image, it can be seen that there are many tdTom+ neurons 
that lack eGFP (and therefore appear red), and that these include PKCγ-immunoreactive 
cells (some of these indicated with arrowheads). The images are projected from 45 optical 
sections at 1 µm z-spacing. The box in c indicates the region shown in Fig 8. Scale bar = 
50 µm. 
Fig 8 Pax2-positive and –negative eGFP-expressing neurons following intraspinal injection of 
AAV.flex.eGFP into a Tac1Cre;Ai9 mouse. Part of the section shown in Fig 7 
(corresponding to the box in Fig 7c) scanned to reveal: (a) tdTom (red), (b) eGFP (green) 
and (c) Pax2 (blue). (d) shows a merged image. Several eGFP+ cells are visible, and all of 
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these are tdTom+. Some of these cells have Pax2-immunoreactivity in their nuclei 
(arrowheads), while others are Pax2-negative (three indicated with arrows). This is a 
projection of 7 optical sections at 1 µm z-spacing. Note that the difference in appearance 
between  the image in d and that seen in Fig 7c is because this shows a more limited 
number of optical sections, and in addition, the blue colour represents Pax2 here, but PKCγ 
in Fig 7c. Scale bar = 20 µm. 
Fig 9 PPTA-immunoreactivity in eGFP-expressing neurons following intraspinal injection of 
AAV.flex.eGFP into a Tac1Cre;Ai9 mouse. The section has been scanned to reveal eGFP 
(green), tdTom (red) and PPTA-immunoreactivity (blue). (a) This field shows several 
eGFP+ neurons and some are indicated with arrows. (b) All of the eGFP+ neurons also 
express tdTom, and there are additional tdTom+ cells that lack eGFP (some marked with 
asterisks). (c) shows PPTA-immunoreactivity in the same field, and in (d) this has been 
merged with tdTom. PPTA can be seen in some of the cells marked with arrows (i.e. those 
that are also eGFP+). It is present in the form of clumps within the perikaryal cytoplasm, 
where it overlaps the tdTom. Note that the tdTom+/eGFP- neurons are not PPTA-
immunoreactive. The section is a projection of 3 optical sections at 0.5 µm z-spacing. Scale 
bar = 20 µm. 
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Table 1 Antibodies used in this study 
 
Antibody Species Dilution Source Catalogue # 
PPTA Guinea pig 1:20,000* T Furuta  
Substance P Rat 1:200 Oxford Biotech OBT06435 
NeuN Mouse 1:1000 Millipore MAB377 
NeuN Chicken 1:1000 Synaptic systems 266 004 
Pax2 Rabbit 1:200-1000 Life Technologies 716000 
VGLUT2 Rabbit 1:5000 Synaptic Systems 135 402 
VGAT Goat 1:1000 M Watanabe  
CGRP Guinea pig 1:10,000 Bachem T-5027 
PKCγ Goat 1:1000 M Watanabe  
Somatostatin Rabbit 1:1000 Peninsula T-4103 
Neurotensin Rat 1:1000 P Ciofi  
EGFP Rabbit 1:1000 M Watanabe  
EGFP Chicken 1:1000 Abcam ab13970 
mCherry rabbit 1:2000 Abcam ab167453 
Fos Goat 1:2000 Santa Cruz Biotechnology sc52-G 
pERK Mouse 1:200 Cell Signaling Technology 9106 
 
*PPTA was detected with the tyramide signal amplification (TSA) method 
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Table 2 The proportions of neurons that express PPTA and/or Pax2 
 Total 
neurons 
% of neurons 
with PPTA 
% of PPTA neurons 
that are Pax2+ 
% of all neurons 
that are Pax2+ 
estimated % of all excitatory 
neurons that are PPTA-
immunoreactive 
Laminae I-II 532 
(484-584) 
13.5% 
(12.7-15.1) 
18.7% 
(16.4-20.9) 
24.7% 
(23.6-26.1) 
14.7% 
(13.4-16.8) 
Lamina III 243.7 
(197-310) 
4.3% 
(3.6-5.6) 
21.3% 
(12.5-33) 
39.5% 
(32.9-45.5) 
4.6% 
(3.4-6.1) 
 
The 2nd-5th columns show the total number of neurons counted as well as the percentages with PPTA- and/or Pax2-immunoreactivity. The 6th column 
shows the percentage of all excitatory neurons that are PPTA-immunoreactive. This was calculated from our previously published estimate that 
excitatory neurons constitute 74.2% of those in laminae I-II and 62.4% of those in lamina III [57]. In each case, the mean value obtained from 3 mice is 
shown, together with the range in brackets. 
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Table 3 The numbers and percentages of Pax2+ and Pax2- neurons in laminae I-II that expressed Fos or pERK following noxious or pruritic 
stimulation 
  Pax2+ Pax2- 
 Total cells Number % of NeuN Fos+/pERK+ %Fos+/pERK+ Number % of NeuN Fos+/pERK+ %Fos+/pERK+ 
Heat 
(n=3) 
593 
(507-664) 
154 
(144-171) 
26.1 
(24.2-28.4) 
79.3 
(72-92) 
51.4* 
(49-53.8) 
439 
(363-493) 
73.9 
(71.6-75.8) 
161.3 
(137-198) 
37* 
(29.7-41) 
Capsaicin 
(n=4) 
260.5 
(222-326) 
71 
(55-92) 
27  
(24.8-29.4) 
19.8 
(13-23) 
28.6 
(22.8-40) 
189.5 
(165-234) 
73 
(70.6-75.2) 
43.5 
(36-60) 
22.8 
(18.8-25.6) 
Chloroquine 
(n=4) 
247 
(175-330) 
65.8 
(54-80) 
27.1 
(24.2-30.9) 
15.8 
(9-25) 
23.8 
(13.6-31.3) 
193.3 
(169-250) 
72.9 
(69.1-75.8) 
44.8 
(31-62) 
22.9 
(17.9-30.4) 
Histamine 
(n=4) 
440 
(339-561) 
124.8 
(84-186) 
27.8 
(24.7-33.1) 
31.8 
(23-41) 
26.4 
(19.9-35.7) 
316 
(255-375) 
72.2 
(66.8-75.2) 
78.8 
(54-123) 
24.7 
(19.0-35.1) 
Pinch 
(n=4) 
392 
(329-459) 
99 
(77-117) 
25.1 
(23.4-26.4) 
44.5 
(36-50) 
45.9* 
(34.6-58.4) 
293 
(252-342) 
74.8 
(73.5-76.5) 
103.7 
(96-114) 
35.7* 
(32.7-41.6) 
 
The 2nd column shows the total numbers of cells analysed for each stimulus, while the 3rd -6th and 7th-10th columns deal with Pax2-positive and Pax2-
negative neurons, respectively. Within each of the sets of columns are shown the number of neurons analysed, the percentage of the total neuronal 
population they account for, the number that were Fos- or pERK-positive, and the proportion that were Fos- or pERK-positive. In all cases values 
represent the means, with the range shown in brackets. Note that numbers in the 4th and 8th columns add up to 100%, since all cells were either defined 
as Pax2-positive or Pax2-negative. *significant difference between the percentage of Pax2-positive and Pax2-negative cells with Fos or pERK. 
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Table 4 The numbers and percentages of excitatory PPTA-immunoreactive neurons in laminae I-II that express Fos or pERK following 
noxious or pruritic stimulation 
 
 
 
 
 
 
 
 
 
 
 
The second column shows the total number of Pax2-negative (excitatory) neurons within the region analysed (data from the 7th column of Table 3), 
while the 3rd-5th columns show the number of PPTA+ cells in this group, the percentage of Pax2-negative cells that they account for, and the percentage 
of excitatory PPTA cells that were Fos- or pERK-positive. For comparison, the 6th column shows the proportion of excitatory (Pax2-negative) neurons 
that were Fos- or pERK-positive (corresponding to column 10 of Table 3). *significant difference between the percentage of PPTA-positive excitatory 
neurons and all excitatory neurons with Fos. 
 Number of Pax2-
neurons 
Number of 
PPTA+/Pax2- 
neurons 
% Pax2- neurons 
that are PPTA+ 
% PPTA+/Pax2- 
neurons that are 
Fos/pERK+ 
% of all Pax2- 
neurons that are 
Fos+/pERK+ 
Heat  
(n=3) 
439 
(363-493) 
53.7 
(48-59) 
12.4 
(10.4-14.9) 
31.5 
(27.8-35.6) 
37 
(29.7-41) 
Capsaicin 
(n=4) 
193.3 
(169-250) 
23 
(13-30) 
12.7 
(6.8-18) 
9.3* 
(0-14.3) 
22.8* 
(18.8-25.6) 
Chloroquine 
(n=4) 
193.3 
(169-250) 
24.8 
(16-33) 
12.7 
(9.2-17.1) 
29.1 
(15.8-45.2) 
22.9 
(17.9-30.4) 
Histamine 
(n=4) 
316 
(255-375) 
41.5 
(32-56) 
13.4 
(8.5-16) 
38.2* 
(34.4-41.2) 
24.7* 
(19.0-35.1) 
Pinch 
(n=4) 
293 
(252-342) 
48.8 
(38-57) 
16.7 
(13.9-20.2) 
47.3 
(34.2-59.6) 
35.7 
(32.7-41.6) 
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Table 5 PKCγ and Pax2 expression by eGFP and tdTom labelled neurons in the Tac1Cre;Ai9 
mice injected with AAV.flex.eGFP 
 
 
 
 
 
 
The table shows results for the eGFP-positive/tdTom-positive (2nd row) and eGFP-negative/tdTom-
positive (3rd row) neurons in the 2 Tac1Cre;Ai9 mice that were injected with AAV.flex.eGFP. In 
each case, the mean value is shown, together with the values from each mouse (in brackets). The 3rd 
column shows the percentage of  neurons in each group that were Pax2-positive. The 4th column 
shows the proportion of neurons of each type that were PKCγ+/Pax2-negative (i.e. excitatory PKCγ 
neurons). 
 Total counted % Pax2+ % PKCγ+/Pax2- 
eGFP+/tdTom+ 181.5 
(172, 191) 
11.2% 
(8.4, 14) 
0.8% 
(0.6, 1) 
eGFP-/tdTom+ 93.5  
(85, 102) 
9.1% 
(8.8, 9.4) 
43.5% 
(40, 47.1) 
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